Americans pay roughly three times as much for prescription meds as people in other wealthy nations. But why?

Tahir Amin argues it’s largely to do with how our patent systems work. He’s been on both sides of the issue: He spent a decade as an intellectual property lawyer, helping corporations use patents to protect their bottom lines. Then he moved to India and saw firsthand how the global patent system hampered access to HIV drugs.

That led him to shift gears and create an advocacy organization aimed at changing the patent system to make access to medicines more equitable. He chats with Flora about how it all works, and his new book, “Pharma Monopoly.”

Read an excerpt from “Pharma Monopoly: The Battle for the Future of Medicines.”

Guest:

Tahir Amin is a co-author of “Pharma Monopoly: The Battle for the Future of Medicines” and a founder and CEO of Initiatives for Medicine Access and Knowledge (I-MAK).

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you hear “colonial America” and “science,” one name probably comes to mind: Benjamin Franklin. But he wasn’t the only one thinking big thoughts and asking big questions. Many other natural philosophers were also looking at the world in new ways, and trying to make sense of how it worked.

In honor of the nation’s 250th birthday, Host Ira Flatow traveled to Boston, the birthplace of the American Revolution, for a conversation with historian Robert Allison about scientific thought in early America.

Guest:

Dr. Robert Allison is a professor of history at Suffolk University, chair of Revolution 250, and president of the Colonial Society of Massachusetts.

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Researchers have engineered an artificial cell out of chemicals and biomolecules that, at a basic level, can eat, grow, duplicate its own genetic code, and reproduce itself. The cell, dubbed SpudCell, is aimed at creating a chassis that can be adapted to create biological factories for the chemicals humans rely on for modern life, from fuels to pharmaceuticals. But it also raises the question of what it means for something to be “alive.”

Synthetic biologist Kate Adamala joins Host Ira Flatow to talk about the technological advance, the possibilities for the artificial cell, and a nonprofit organization she hopes will allow the SpudCell to spark an innovation in biotechnology.

Guest:

Dr. Kate Adamala is a synthetic biologist and an associate professor of genetics, cell biology, and development at the University of Minnesota.

Transcripts for each episode are available within 1-3 days at sciencefriday.com.

Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.